Strategic partnerships NRG Oncology actively expands its network through international collaborations and industry partnerships, signaling strong potential to engage technology and data partners (e.g., TROG, Flatiron Health) to scale multi-site clinical trials and data integration initiatives.

Technology enabled trials The organization already leverages modern tech stacks and integrations (Flatiron Clinical Pipe, Azure, Google Tag Manager) indicating readiness to adopt additional digital health and data management solutions to streamline study operations and patient recruitment.

Clinical trial network With a broad NCI National Clinical Trials Network presence and 1,300+ sites, NRG Oncology presents a substantial channel for scalable trials, offering opportunities for vendors providing trial management platforms, EHR integration, patient engagement tools, and analytics.

Funding scale Annual revenue in the mid-range with nonprofit funding goals creates potential for partnerships with philanthropic organizations, sponsors, and technology providers seeking alignment with mission-driven cancer research and dissemination.

Leadership and expansion Recent leadership appointments in Canada and ongoing governance enhancements indicate openness to regional collaborations and new market entry strategies, presenting opportunities for localized solutions, regulatory support, and cross-border trial operations.